These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11470333)

  • 1. Immune-endocrine status and coeliac disease in children with Down's syndrome: relationships with zinc and cognitive efficiency.
    Licastro F; Mariani RA; Faldella G; Carpenè E; Guidicini G; Rangoni A; Grilli T; Bazzocchi G
    Brain Res Bull; 2001 May; 55(2):313-7. PubMed ID: 11470333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proapoptotic activated T-cells in the blood of children with Down's syndrome: relationship with dietary antigens and intestinal alterations.
    Corsi MM; Ponti W; Venditti A; Ferrara F; Baldo C; Chiappelli M; Licastro F
    Int J Tissue React; 2003; 25(3):117-25. PubMed ID: 14756193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid function and plasma immunoglobulins in subjects with Down's syndrome (DS) during ontogenesis and zinc therapy.
    Sustrová M; Strbák V
    J Endocrinol Invest; 1994 Jun; 17(6):385-90. PubMed ID: 7930384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zinc affects the metabolism of thyroid hormones in children with Down's syndrome: normalization of thyroid stimulating hormone and of reversal triiodothyronine plasmic levels by dietary zinc supplementation.
    Licastro F; Mocchegiani E; Zannotti M; Arena G; Masi M; Fabris N
    Int J Neurosci; 1992; 65(1-4):259-68. PubMed ID: 1341688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diminished zinc plasma concentrations and alterations in the number of lymphocyte subpopulations in Down's syndrome patients].
    Soto-Quintana M; Alvarez-Nava F; Rojas-Atencio A; Granadillo V; Fernández D; Ocando A; López E; Fulcado W
    Invest Clin; 2003 Mar; 44(1):51-60. PubMed ID: 12703183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down's syndrome and celiac disease: the prevalence of high IgA-antigliadin antibodies and HLA-DR and DQ antigens in trisomy 21.
    Castro M; Crinò A; Papadatou B; Purpura M; Giannotti A; Ferretti F; Colistro F; Mottola L; Digilio MC; Lucidi V
    J Pediatr Gastroenterol Nutr; 1993 Apr; 16(3):265-8. PubMed ID: 8492253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of the neuroendocrine system and immune functions by zinc supplementation in children with Down's syndrome.
    Licastro F; Mocchegiani E; Masi M; Fabris N
    J Trace Elem Electrolytes Health Dis; 1993 Dec; 7(4):237-9. PubMed ID: 8019155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunodeficiency and plasma zinc levels in children with Down's syndrome: a long-term follow-up of oral zinc supplementation.
    Stabile A; Pesaresi MA; Stabile AM; Pastore M; Sopo SM; Ricci R; Celestini E; Segni G
    Clin Immunol Immunopathol; 1991 Feb; 58(2):207-16. PubMed ID: 1824686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological features of Down's syndrome: a review.
    Nespoli L; Burgio GR; Ugazio AG; Maccario R
    J Intellect Disabil Res; 1993 Dec; 37 ( Pt 6)():543-51. PubMed ID: 8124000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological studies of patients with Down's syndrome. Measurements of autoantibodies and serum antibodies to dietary antigens in relation to zinc levels.
    Kanavin O; Scott H; Fausa O; Ek J; Gaarder PI; Brandtzaeg P
    Acta Med Scand; 1988; 224(5):473-7. PubMed ID: 2974234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of peripheral blood T-cell subsets, natural killer cells and serum levels of cytokines in children with Down syndrome.
    Cetiner S; Demirhan O; Inal TC; Tastemir D; Sertdemir Y
    Int J Immunogenet; 2010 Aug; 37(4):233-7. PubMed ID: 20477881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of blood cell populations, plasma zinc and natural killer cell activity in young children with Down's syndrome.
    Noble RL; Warren RP
    J Ment Defic Res; 1988 Jun; 32 ( Pt 3)():193-201. PubMed ID: 2971114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperthyrotropinaemia in untreated subjects with Down's syndrome aged 6 months to 64 years: a comparative analysis.
    Meyerovitch J; Antebi F; Greenberg-Dotan S; Bar-Tal O; Hochberg Z
    Arch Dis Child; 2012 Jul; 97(7):595-8. PubMed ID: 22535238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood zinc in patients with Down's syndrome and its relations with their immune status].
    Colombo ML; Givrardo E; Ricci BM; Maina D
    Minerva Pediatr; 1989 Feb; 41(2):71-5. PubMed ID: 2525662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a relationship between zinc and the peculiar comorbidities of Down syndrome?
    Romano C; Pettinato R; Ragusa L; Barone C; Alberti A; Failla P
    Downs Syndr Res Pract; 2002 Mar; 8(1):25-8. PubMed ID: 11915434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of coeliac disease in Down's syndrome in Malta.
    Sciberras C; Vella C; Grech V
    Ann Trop Paediatr; 2004 Mar; 24(1):81-3. PubMed ID: 15005971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid dysfunction and high thyroid stimulating hormone levels in children with Down's syndrome.
    Gruñeiro de Papendieck L; Chiesa A; Bastida MG; Alonso G; Finkielstain G; Heinrich JJ
    J Pediatr Endocrinol Metab; 2002; 15(9):1543-8. PubMed ID: 12503863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related changes in humoral and cell-mediated immunity in Down syndrome children living at home.
    Lockitch G; Singh VK; Puterman ML; Godolphin WJ; Sheps S; Tingle AJ; Wong F; Quigley G
    Pediatr Res; 1987 Nov; 22(5):536-40. PubMed ID: 2960948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid dysfunction in Down's syndrome.
    Loudon MM; Day RE; Duke EM
    Arch Dis Child; 1985 Dec; 60(12):1149-51. PubMed ID: 2936311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD3+/CD30+ circulating T lymphocytes are markedly increased in older subjects with Down's syndrome (Trisomy 21).
    Bertotto A; Crupi S; Fabietti GM; Troiani S; Parente C; Mezzetti D; Vaccaro R
    Pathobiology; 1999; 67(2):108-10. PubMed ID: 10023139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.